Know Cancer

or
forgot password


Phase 3
20 Years
75 Years
Open (Enrolling)
Both
Lung Cancer

Thank you

Trial Information


Inclusion Criteria:



1. completely resected non small cell lung cancer

2. no prior anti cancer treatment for thoracic malignancy exept for this operation

3. pathological stage IB, II, and stage IIIA with only one station of n2 disease

4. PS 0-1

5. age 20-75

6. adequate organ function for chemotherapy

7. written informed consent

Exclusion Criteria:

1. small cell lung cancer or low grade malignancy of lung cancer

2. incomplete resection

3. apparent interstitial pneumonitis at chest rentogenogram

4. inadequate condition for chemotherapy

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

5 year survival rate

Principal Investigator

Hirohito Tada, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

West Japan Thoracic Oncology Group

Authority:

Japan: Ministry of Health, Labor and Welfare

Study ID:

WJTOG0101

NCT ID:

NCT00139971

Start Date:

December 2001

Completion Date:

Related Keywords:

  • Lung Cancer
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location